Feedback / Questions
gengleucel (IGNK001) - Ingenium Therap
https://www.prnewswire.com/news-releases/ingenium-therapeutics-receives-fda-feedback-enabling-direct-phase-2-trial-for-gengleucel-in-mrd-aml-302442593.html
Apr 30, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next